Difficulty: Medium
Average Score: 73%
Practice
You are managing a stable middle-aged adult with emphysema. In addition to reinforcing smoking cessation and medication schedules which annual intervention will you recommend?
Correct answer
A
Rationale
The correct answer is A: Pneumococcal polysaccharide vaccine (PPSV23). This vaccine is recommended for adults with chronic lung conditions like emphysema to prevent pneumococcal infections. It helps in reducing the risk of pneumonia and its complications.
Rationale:
1. PPSV23 is specifically indicated for adults with chronic medical conditions, including emphysema.
2. Emphysema puts the individual at a higher risk for respiratory infections, including pneumococcal infections.
3. PPSV23 provides protection against pneumococcal bacteria, which is a common cause of pneumonia.
4. Administering PPSV23 annually helps maintain immunity and reduces the likelihood of pneumococcal infections in high-risk individuals.
Summary:
B: Pneumococcal conjugate vaccine (PCV13) is primarily recommended for children, not for stable middle-aged adults with emphysema.
C: Quadrivalent inactivated
Rationale:
1. PPSV23 is specifically indicated for adults with chronic medical conditions, including emphysema.
2. Emphysema puts the individual at a higher risk for respiratory infections, including pneumococcal infections.
3. PPSV23 provides protection against pneumococcal bacteria, which is a common cause of pneumonia.
4. Administering PPSV23 annually helps maintain immunity and reduces the likelihood of pneumococcal infections in high-risk individuals.
Summary:
B: Pneumococcal conjugate vaccine (PCV13) is primarily recommended for children, not for stable middle-aged adults with emphysema.
C: Quadrivalent inactivated